Veracyte | VCYT - Stammkapital





Stammkapital Veränderung Datum
Agenus USD 35.32M 2.51M 2025-12
Agilent USD 282.22M 478K 2026-03
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 137.39M 1.69M 2025-12
Bruker USD 152.22M 282K 2026-03
Heron Therapeutics USD 188.31M 4.99M 2025-12
Illumina USD 151.91M 893K 2026-03
Intrexon USD 0 0 2024-06
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Laboratory Of America USD 82.3M 100K 2026-03
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Rigel Pharmaceuticals USD 17K 158K 2024-06
Roche Holding CHF 796.77M 1.15M 2026-06
Siemens EUR 780.74M 6.33M 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Thermo Fisher Scientific USD 371.62M 1000 2026-06
Veracyte USD 79.79M 743K 2026-03
Waters USD 98.17M 89K 2026-03